St�Ephane Bergez - Profile and Investment Details

Investor Profile

St�Ephane Bergez is a Venture Capital, Private Equity Firm based in Paris, Île-de-France, France with a diverse investment portfolio that includes companies such as Genoa Pharmaceuticals, ENYO Pharma, OncoEthix, AM Pharma, MedDay, HighLife, Groupe ADFGroupe JORYF, Sogetrel, Biogroup-LCD, MMI, Thomson Video Networks, Crescendo Biologics, Netco, Bacacier group, ACE Group, Complexa, walor, Ipside, Genkyotex, Complix, ace credit, SANIFIT, Atlantic Therapeutics, Altavia, Verona Pharma, Chase Pharmaceuticals, Loyalty Company, The Bioclinic Group, Groupe 3S, T-knife, Endosense, Poxel, HR Path, Axonics Modulation Technologies, La Vie Saine, Sfam, Mondial Pet Distribution, Sirsa, ReViral, In'Tech Medical, Inotrem, A2IA, Opportunity, Artios Pharma, GamaMabs Pharma, Corvidia, Mastergrid, Minafin, Maesa Group, Finsecur, orbility, Solware Group, Exciva, Covagen, Avalyn Pharma, LogicBio Therapeutics, erytech, Groupe ERGET, Atland, Medlumics, The Reefer Group, Studia group, Travelsoft, REALEASE Capital, Rougnon, Fortesan, La Toulousaine, Grey Wolf Therapeutics, Globe Groupe, Autonomic Technologies, Tournus Equipement, JenaValve Technology, SPHEREA, Allecra Therapeutics, MS Vacances, Passman, Emeraude International, Dynacure, Tricares, Pennel & Flipo, AgomAb Therapeutics, Arvelle Therapeutics, . Over time, St�Ephane Bergez has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether St�Ephane Bergez is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Wearables, Hospitals, Wellness, CRM, Life Science, Robotics, Information Technology (IT), Biotechnology, Consulting, Medical, SaaS, Therapeutics, Pharmaceuticals may find it worthwhile to explore potential connections with St�Ephane Bergez, as their portfolio suggests a familiarity and interest in this area.

Understanding St�Ephane Bergez’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.